1. Diabetes Obes Metab. 1999 Nov;1(6):317-22. doi: 
10.1046/j.1463-1326.1999.00042.x.

Metabolic effects of moxonidine and other centrally acting antihypertensives.

Schachter M(1).

Author information:
(1)Department of Clinical Pharmacology and Therapeutics, Imperial College School 
of Medicine, St Mary's Hospital, London, UK. M.Schachter@ic.ac.uk

DOI: 10.1046/j.1463-1326.1999.00042.x
PMID: 11225647 [Indexed for MEDLINE]
